| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
1,622
|
19,851
|
1,875
|
16,298
| | Cost of Revenue | 375 | 785 | 375 | 375 | | |
Gross Profit
|
1,247
|
19,067
|
1,500
|
15,923
| |
|
Operating Expenses |
|
Research Development | 12,032 | 11,561 | 12,546 | 6,547 |
|
Selling General and Administrative | 2,927 | 2,097 | 3,012 | 2,229 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(13,712)
|
5,408
|
(14,059)
|
7,148
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,074 | 3,036 | (3,418) | (3,365) |
|
Earnings Before Interest And Taxes | (12,638) | 8,725 | (17,477) | 3,783 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (12,638) | 8,725 | (17,477) | 3,783 |
|
Income Tax Expense | 85 |
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (12,723) | 8,596 | (17,477) | 3,783 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(12,723)
|
8,596
|
(17,477)
|
3,783
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(12,723)
|
8,596
|
(17,477)
|
3,783
|
|
0.12(2.65%) 10:38AM EDT - Nasdaq Real Time Price